The Board of DSS, Inc. (NYSEAM:DSS) intent to spin-off Impact BioMedical Inc on June 2, 2023. DSS through its subsidiary BioHealth Security, Inc plans to distribute an aggregate of approximately 486,706,712 shares of our Common Stock beneficially held by DSS BioHealth Security, Inc. in a distribution to holders of DSS common stock as of June 30, 2023. DSS shareholder will receive four shares of Impact Biomedical, Inc. for every one share of DSS.

Allowing the Distribution DSS, through its wholly-owned subsidiary DSS BioHealth Security, Inc., will retain approximately an 87% ownership interest in the Company. The Distribution will not occur until this Registration Statement becomes effective under the Securities Act. The Distribution will be effective on July 14, 2023.

As of June 30, 2023, the record date of the transaction has been revised to July 10, 2023. As of July 31, 2023, the distribution date for the stock dividend is set to be August 8, 2023. Shares will be registered under CUSIP Number 45259L 106.

Each share of Impact BioMedical distributed as part of the distribution will not be eligible for resale until 180 days from the date Impact BioMedical?s initial public offering becomes effective under the Securities Act, subject to the discretion of the Company to lift the restriction sooner. American Stock Transfer & Trust Company and V Stock Transfer acted as transfer agent to DSS and Impact respectively.